References

Bennett MR (2000) The concept of transmitter receptors: 100 years on. Neuropharmacology 39:523-546.

Berg KA, Cropper JD, King BD, et al (2003) Effector pathway-dependence of ligand-independent 5-HT2C receptor activity. FASEB J 17:A1021.

Bonhaus DW, Weinhardt KK, Taylor M, et al (1997) RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist. Neuropharmacology 36:621-629.

Bradley PB, Engel G, Feniuk W, et al (1986) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25:563-576.

Bubar MJ, Cunningham KA (2006) Serotonin 5-HT2A and 5-HT2C receptors as potential targets for modulation of psychostimulant use and dependence. Curr Top Med Chem 6:1971-1985.

Bubar MJ, Cunningham KA (2007) Distribution of serotonin 5-HT2C receptors in the ventral tegmental area. Neuroscience 146:286-297.

Burns CM, Chu H, Rueter SM, et al (1997) Regulation of 5-HT2C receptor G-protein coupling by RNA editing [see comments]. Nature 387:303-308.

Canton H, Emeson RB, Barker EL, et al (1996) Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing. Mol Pharmacol 50:799-807.

Closse A (1983) [3H]Mesulergine, a selective ligand for serotonin-2 receptors. Life Sci 32:2485-2495.

Conn PJ, Sanders-Bush E, Hoffman BJ, et al (1986) A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover. Proc Natl Acad Sci USA 83:4086-4088.

Cremers TI, Rea K, Bosker FJ, et al (2007) Augmentation of SSRI effects on serotonin by 5-HT2C antagonists: mechanistic studies. Neuropsychopharmacology 32:1550-1557.

Di Giovanni G, De Deurwaerdere P, Di Mascio M, et al (1999) Selective blockade of serotonin2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study. Neuroscience 91:587-597.

Du Y, Stasko M, Costa AC, et al (2007) Editing of the serotonin 2C receptor pre-mRNA: effects of the Morris Water Maze. Gene 391:186-197.

Engel G, Hoyer D, Berthold R, et al (1981) (+/-)[125Iodo] cyanopindolol, a new ligand for beta-adrenoceptors: identification and quantitation of subclasses of beta-adrenoceptors in guinea pig. Naunyn Schmiedebergs Arch Pharmacol 317:277-285.

Engel G, Hoyer D, Kalkman HO, et al (1984) Identification of 5HT2-receptors on longitudinal muscle of the guinea pig ileum. J Recept Res 4:113-126.

Engel G, Göthert M, Hoyer D, et al (1986) Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites. Naunyn Schmiedebergs Arch Pharmacol 332:1-7.

Enz A, Donatsch P, Nordmann R (1984) Dopaminergic properties of mesulergine (CU 32-085) and its metabolites. J Neural Transm 60:225-238.

Fitzgerald LW, Burn TC, Brown BS, et al (2000) Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine. Mol Pharmacol 57:75-81.

Foguet M, Hoyer D, Pardo LA, et al (1992) Cloning and functional characterization of the rat stomach fundus serotonin receptor. EMBO J 11:3481-3487.

Foguet M, Nguyen H, Le H, Lubbert H (1992) Structure of the mouse 5-HT1C, 5-HT2 and stomach fundus serotonin receptor genes. NeuroReport 3:345-348.

Gaddum JH, Picarelli ZP (1957) Two kinds of tryptamine receptor. Br J Pharmacol 12:323-328.

Gozlan H, el Mestikawy S, Pichat L, et al (1983) Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature 305:140-142

Guth PS (1982) The structurally specific, stereospecific, saturable binding of pepperoni to pizza. Trends Pharmacol Sci 3:467.

Hackler EA, Airey DC, Shannon CC, et al (2006) 5-HT(2C) receptor RNA editing in the amygdala of C57BL/6 J, DBA/2 J, and BALB/cJ mice. Neurosci Res 55:96-104.

Hackler EA, Turner GH, Gresch PJ, et al (2007) 5-Hydroxytryptamine2C receptor contribution to m-chlorophenylpiperazine and N-methyl-beta-carboline-3-carboxamide-induced anxiety-like behavior and limbic brain activation. J Pharmacol Exp Ther 320:1023-1029.

Hartig PR, Hoyer D, Humphrey PP, et al (1996) Alignement of receptor nomenclature with the human genome: classification of 5-HT1B and 5-HT1D receptor subtypes. Trends Pharmacol Sci 17:103-105.

Herrick-Davis K, Grinde E, Niswender CM (1999) Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction. J Neurochem 73:1711-1717.

Herrick-Davis K, Grinde E, Teitler M (2000) Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors. J Pharmacol Exp Ther 295:226-232.

Hjorth S, Carlsson A, Lindberg P, et al (1982) 8-hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity. J Neural Transm 55:169-188.

Hoyer D (1988) Molecular pharmacology and biology of 5-HT1C receptors. Trends Pharmacol Sci 9:89-94.

Hoyer D (1988) Molecular pharmacology and biology of 5-HT1C receptors. Trends Pharmacol Sci 9:89-94.

Hoyer D, Middlemiss DN (1989) Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain. Trends Pharmacol Sci 10:130-132.

Hoyer D, Engel G, Berthold R (1982) Binding characteristics of (+)-, (+/-)- and (-)-[125iodo] cyanopindolol to guinea-pig left ventricle membranes. Naunyn Schmiedebergs Arch Pharmacol 318:319-329.

Hoyer D, Engel G, Kalkman HO (1985) Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. Eur J Pharmacol 118:13-23.

Hoyer D, Engel G, Kalkman HO (1985) Characterization of the 5-HT1B recognition site in rat brain: binding studies with 125I-iodocyanopindolol. Eur J Pharmacol 118:1-12.

Hoyer D, Pazos A, Probst A, et al (1986) Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites. Brain Res 376:97-107.

Hoyer D, Srivatsa S, Pazos A, et al (1986) [125I]LSD labels 5-HT1C recognition sites in pig choroid plexus membranes. Comparison with [3H]mesulergine and [3H]5-HT binding. Neurosci Lett 69:269-274.

Hoyer D, Pazos A, Probst A, et al (1986) Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain Res 376:85-96.

Hoyer D, Pazos A, Probst A, et al (1986) Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites. Brain Res 376:97-107.

Hoyer D, Waeber C, Schoeffter P, et al (1989) 5-HT1C receptor-mediated stimulation of inositol phosphate production in pig choroid plexus. A pharmacological characterization. Naunyn Schmiedebergs Arch Pharmacol 339:252-258.

Hoyer D, Clarke DE, Fozard JR, et al (1994) International Union of Pharmacology classification of receptors for 5- hydroxytryptamine (Serotonin). Pharmacol Rev 46:157-203.

Humphrey PPA, Hartig P, Hoyer D (1993) A proposed new nomenclature for 5-HT receptors. Trends Pharmacol Sci 14:233-236.

Iwamoto K, Nakatani N, Bundo M, et al (2005) Altered RNA editing of serotonin 2C receptor in a rat model of depression. Neurosci Res 53:69-76.

Julius D, MacDermott AB, Axel R, et al (1988) Molecular characterization of a functional cDNA encoding the serotonin 1c receptor. Science 241:558-564.

Kalkman HO, Engel G, Hoyer D (1986) Inhibition of 5-carboxamidotryptamine-induced relaxation of guinea-pig ileum correlates with [125I]LSD binding. Eur J Pharmacol 129:139-145.

Laduron PM (1984) Criteria for receptor sites in binding studies. Biochem Pharmacol 33:833-839.

Lefkowitz RJ (2004) Historical review: a brief history and personal retrospective of seven-transmembrane receptors. Trends Pharmacol Sci 25:413-422.

Lindvall-Axelsson M, Mathew C, Nilsson C, et al (1988) Effect of 5-hydroxytryptamine on the rate of cerebrospinal fluid production in rabbit. Exp Neurol 99:362-368.

Lubbert H, Hoffman BJ, Snutch TP, et al (1987) cDNA cloning of a serotonin 5-HT1C receptor by electrophysiological assays of mRNA-injected Xenopus oocytes. Proc Natl Acad Sci USA 84:4332-4336.

Markstein R (1983) Mesulergine and its 1,20-N,N-bidemethylated metabolite interact directly with D1- and D2-receptors. Eur J Pharmacol 95:101-107.

Markstein R, Hoyer D, Engel G (1986) 5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus. Naunyn Schmiedebergs Arch Pharmacol 333:335-341.

Mengod G, Nguyen H, Le H, et al (1990) The distribution and cellular localization of the serotonin 1C receptor mRNA in the rodent brain examined by in situ hybridization histochemistry. Comparison with receptor binding distribution. Neuroscience 35:577-591.

Middlemiss DN, Fozard JR (1983) 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site. Eur J Pharmacol 90:151-153.

Millan MJ, Gobert A, Lejeune F, et al (2003) The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J Pharmacol Exp Ther 306:954-964.

Niswender CM, Copeland SC, Herrick-Davis K, et al (1999) RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. J Biol Chem 274:9472-9478.

Niswender CM, Herrick-Davis K, Dilley GE, et al (2001) RNA editing of the human serotonin 5-HT2C receptor. Alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology 24:478-491.

Palacios JM, Markstein R, Pazos A (1986) Serotonin-1C sites in the choroid plexus are not linked in a stimulatory or inhibitory way to adenylate cyclase. Brain Res 380:151-154.

Pazos A, Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res 346:205-230.

Pazos A, Hoyer D, Palacios JM (1984) The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. Eur J Pharmacol 106:539-546.

Pazos A, Hoyer D, Palacios JM (1984a) Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: evidence for species differences in brain serotonin-2 receptors. Eur J Pharmacol 106:531-538.

Pazos A, Cortés R, Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res 346:231-249.

Pazos A, Probst A, Palacios JM (1987) Serotonin receptors in the human brain. III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience 21:97-122.

Pazos A, Probst A, Palacios JM (1987) Serotonin receptors in the human brain. IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience 21:123-139.

Pedigo NW, Yamamura HI, Nelson DL (1981) Discrimination of multiple [3H]5-hydroxytriptam-ine-binding sites by the neuroleptic spiperone in rat brain. J Neurochem 36:220-226.

Peroutka SJ, Snyder SH (1979) Multiple serotonin receptors: differential binding of [3H]5-hy-droxytryptamine, [3H]lysergic acid die ethylamide and [3H]spiroperidol. Mol Pharmacol 16:687-699.

Pompeiano M, Palacios JM, Mengod G (1994) Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Brain Res Mol Brain Res 23:163-178.

Price RD, Sanders-Bush E (2000) RNA editing of the human serotonin 5-HT(2C) receptor delays agonist-stimulated calcium release. Mol Pharmacol 58:859-862.

Price RD, Weiner DM, Chang MS, et al (2001) RNA editing of the human serotonin 5-HT2C receptor alters receptor-mediated activation of G13 protein. J Biol Chem 276:44663-44668.

Pritchett DB, Bach AW, Wozny M, et al (1988) Structure and functional expression of cloned rat serotonin 5HT-2 receptor. EMBO J 7:4135-4140.

Schoeffter P, Hoyer D (1989) 5-Hydroxytryptamine 5-HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase activity. Pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some beta-adrenoceptor antagonists. Naunyn Schmiedebergs Arch Pharmacol 340:285-292.

Schoeffter P, Hoyer D (1989) 5-Hydroxytryptamine 5-HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase activity. Pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some beta-adrenoceptor antagonists. Naunyn Schmiedebergs Arch Pharmacol 340:285-292.

Sodhi MS, Burnet PW, Makoff AJ, et al (2001) RNA editing of the 5-HT(2C) receptor is reduced in schizophrenia. Mol Psychiatry 6:373-379.

Tecott LH, Abdallah L (2003) Mouse genetic approaches to feeding regulation: serotonin 5-HT2C receptor mutant mice. CNS Spectr 8:584-588.

Tecott LH, Sun LM, Akana SF, et al (1995) Eating disorder and epilepsy in mice lacking 5-HT^ serotonin receptors [see comments]. Nature 374:542-546.

Defeat Drugs and Live Free

Defeat Drugs and Live Free

Being addicted to drugs is a complicated matter condition that's been specified as a disorder that evidences in the obsessional thinking about and utilization of drugs. It's a matter that might continue to get worse and become disastrous and deadly if left untreated.

Get My Free Ebook


Post a comment